CSPC PHARMA(01093.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 859.79 million, YoY decrease of 41.83%

NewTimeSpace News: May 27, 2026, CSPC PHARMA(01093.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at CNY 6.47 billion, decreased by 7.83% YoY; Net Profit stood at CNY 890.48 million, YoY decrease of 40.43%; Profit Attributable to Shareholders stood at CNY 859.79 million, YoY decrease of 41.83%; Basic Earnings Per Share (EPS) stood at CNY cents 7.54.
In terms of profitability, CSPC PHARMA Gross Profit changed from CNY 4.71 billion in the same period last year to CNY 4.27 billion in the current period, decreased by CNY 436.84 million; gross profit margin changed from 67.08% in the same period last year to 66.02% in the current period, decreased by 1.06 percentage points; net profit changed from CNY 1.49 billion in the same period last year to CNY 890.48 million in the current period, decreased by CNY 604.3 million; net profit margin changed from 21.31% in the same period last year to 13.77% in the current period, decreased by 7.54 percentage points.
In terms of earnings quality, CSPC PHARMA Operating Profit changed from CNY 1.79 billion in the same period last year to CNY 1.16 billion in the current period, decreased by CNY 636.99 million; Operating Profit Margin changed from 25.55% in the same period last year to 17.87% in the current period, decreased by 7.68 percentage points.
In terms of R&D investment focus, CSPC PHARMA R&D Expenses changed from CNY 1.3 billion in the same period last year to CNY 1.4 billion in the current period, increased by CNY 100.5 million; R&D to Total Revenue Ratio changed from 18.56% in the same period last year to 21.7% in the current period, increased by 3.14 percentage points.
By the close of trading on May 26, 2026, CSPC PHARMA(01093) saw a loss of 3.25% in its share price, closing at HKD 7.44. The full-day turnover stood at HKD 576.93 million, with the latest market capitalization at HKD 85.73 billion.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.